Camden Capital, LLC

SEC CIK: 0001800752
Latest filing: Jul 28, 2026

SEC filings (opens in a new tab)

ROIV holding history

Roivant Sciences Ltd. in every 13F filed by Camden Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ROIV overview All 13F holders of ROIV Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of ROIV by Camden Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−10,000−100.0%	Sold out	Holders
Q1 2025	10,000	$100.9K	<0.1%	00.0%	Unchanged	Holders
Q4 2024	10,000	$118.3K	<0.1%	00.0%	Unchanged	Holders
Q3 2024	10,000	$115.4K	<0.1%	+10,000	New	Holders